MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 10897-10904

  Li, Wentao ^a   Zang, Wenqiao ^a   Liu, Pei ^a   Wang, Yuanyuan ^a   Du, Yuwen ^a   Chen, Xiaonan ^a   Deng, Meng ^a   Sun, Wencong ^a   Wang, Lei ^a   Zhao, Guoqiang ^a   Zhai, Baoping ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; Ets 1; Invasion; miR 124; Proliferation

Indexed keywords

3' UNTRANSLATED REGION; MESSENGER RNA; MICRORNA; MIRN124 MICRORNA, HUMAN; TRANSCRIPTION FACTOR ETS 1;

3' UNTRANSLATED REGION; APOPTOSIS; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; PROTO-ONCOGENE PROTEIN C-ETS-1; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84928585732     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2402-2     Document Type: Article

References (38)

1. Abdelrahim M, Smith 3rd R, Burghardt R. Safe S role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 2004;64(18):6740–9.
2. Brennecke J, Cohen SM. Towards a complete description of the microRNA complement of animal genomes. Genome Biol. 2003;4(9):228.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.
4. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–33.
5. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 1983;35(1):79–87.
6. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.
7. Esteller M. Non coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–74.
8. Gao Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008;68(1):26–33.
9. Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 2011;6(3):e18286.
10. Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, et al. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer. PLoS One. 2014;9(6):e96767.
11. Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: systematic review. World J Gastrointest Pathophysiol. 2014;5(2):63–70.
12. Iorio MV, Visone R, Di LG, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67(18):8699–707.
13. Wang T, Zang W-q, Li M, Wang N, Zheng Y-l, Zhao G-q. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58(3):706–14.
14. Kim IK, Jung YK, Noh DY, Song YS, Choi CH, Oh BH, et al. Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2. Br J Cancer. 2003;88(6):910–7.
15. Kong LM, Liao CG, Fei F, Guo X, Xing JL, Chen ZN. Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci. 2010;101(6):1463–70.
16. Kozomara A, Griffiths Jones S. miRBase: integrating microRNA annotation and deep sequencing data. Nucleic Acids Res. 2011;39:D152–7.
17. Benson JR, Jatoi I. The global breast cancer burden. Future Oncol. 2012;8:697–702.
18. Honrado E, Benítez J, Palacios J. The molecular pathology of hereditary breast cancer genetic testing and therapeutic implications. Mod Pathol. 2005;18:1305–20.
19. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene. 2002;21:8506–9.
20. Gilles C, Polette M, Birembaut P, Brünner N, Thompson EW. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis. 1997;15:519–26.
21. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. Eur J Biochem. 1993;211:7–18.
22. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005;41:2462–78.
23. Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O'Higgins N, et al. Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer. 2004;91:1308–15.
24. Li R, Pei H, Watson DK. Regulation of Ets function by protein–protein interactions. Oncogene. 2000;19:6514–23.
25. Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem. 2004;91:896–903.
26. Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13:394–406.
27. Maroulakou IG, Bowe DB. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene. 2000;19:6432–42.
28. Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet. 2005;14(Spec No1):R121–32.
29. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690–5.
30. Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cell Oncol. 2013;36(1):1–7.
31. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451(7175):147–52.
32. Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, et al. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer. 2013;12:163.
33. Zhang H, Wang Q, Zhao Q, Di W. MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res. 2013;6(1):84.
34. Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie Y, et al. microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem. 2014;392(1–2):153–9.
35. Fafeur V, Tulasne D, Queva C, Vercamer C, Dimster V, Mattot V, et al. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ. 1997;8:655–65.
36. Delannoy-Courdent A, Fauquette W, Dong-Le Bourhis XF, Boilly B, Vandenbunder B, Desbiens X. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. Int J Dev Biol. 1996;40:1097–108.
37. Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol. 2001;194:43–50.
38. Katayama S, Nakayama T, Ito M, Naito S, Sekine I. Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol Histopathol. 2005;20:119–26.